, , , , , , , ,

JNJ’s Medical Devices Business Faces Another Recall With Stapler — Trefis.

Johnson & Johnson (NYSE:JNJ) and recalls have started to seem like synonyms as the company is hit with another recall relating to its surgical stapler devices, which could pose serious health issues for patients. The company will recall as much as 157,000 stapler devices after the U.S. FDA tagged the recall as class I, the most serious. 

The recall comes barely within two months of recent recall of the company’s Hemostatic Bone Putty, and  may not bode well for the company, which is grappling to revive its Medical Devices & Diagnostics division.

The company’s brand value took a hit following the DePuy metal hip implants recall and related lawsuits. With its $21 billion Synthes aquisition, Johnson & Johnson is hoping to recover from these setbacks.

For the full article – click here.